Indivior Pharmaceuticals (INDV) EBITDA Margin (2024 - 2026)
Indivior Pharmaceuticals' (INDV) quarterly EBITDA Margin came in at 43.22% in Q1 2026, up 1841.0% year-on-year from 2.23% in Q1 2025, and up 91.01% quarter-over-quarter from 22.63% in Q4 2025.
Indivior Pharmaceuticals (INDV) EBITDA Margin (2024 - 2026) Analysis & Trends
Indivior Pharmaceuticals' EBITDA Margin history runs 3 years deep, the most recent figure standing at 43.22% for Q1 2026.
- On a quarterly basis, EBITDA Margin rose 1841.0% year-over-year to 43.22% in Q1 2026; TTM through Mar 2026 was 25.79%, a 2332.0% increase from a year earlier, with the FY2025 full-year figure at 21.15%, up 1795.0% from the prior year.
- EBITDA Margin advanced to 43.22% in Q1 2026 per INDV's latest filing, from 22.63% in the prior quarter.
- Across five years, EBITDA Margin topped out at 43.22% in Q1 2026 and bottomed at 39.46% in Q2 2024.
- The 3-year median for EBITDA Margin is 22.63% (2025), against an average of 15.77%.
- Biggest YoY gain for EBITDA Margin was 6331 bps in 2025; the steepest drop was 160 bps in 2025.
- Year by year, EBITDA Margin stood at 15.38% in 2024, then soared by 47 bps to 22.63% in 2025, then surged by 91 bps to 43.22% in 2026.
- Per Business Quant, the three latest INDV EBITDA Margin figures stand at 43.22% (Q1 2026), 22.63% (Q4 2025), and 13.69% (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 16.37% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 36.83% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -38.02% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 41.69% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -2.27% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 23.74% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 21.23% |
| 10 | Indivior Pharmaceuticals | 1.00 Bn | 829.65 Mn | 277.00 Mn | 43.22% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 43.22% |
| Dec 31, 2025 | 22.63% |
| Sep 30, 2025 | 13.69% |
| Jun 30, 2025 | 23.84% |
| Mar 31, 2025 | 24.81% |
| Dec 31, 2024 | 15.38% |
| Sep 30, 2024 | 11.40% |
| Jun 30, 2024 | -39.46% |
| Mar 31, 2024 | 26.41% |